Bristol-myers Squibb Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRISTOL-MYERS SQUIBB, and when can generic versions of BRISTOL-MYERS SQUIBB drugs launch?
BRISTOL-MYERS SQUIBB has one approved drug.
There are five US patents protecting BRISTOL-MYERS SQUIBB drugs.
There are eighty-one patent family members on BRISTOL-MYERS SQUIBB drugs in thirty-one countries and nineteen supplementary protection certificates in sixteen countries.
Summary for Bristol-myers Squibb
International Patents: | 81 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Bristol-myers Squibb: | See patent lawsuits for Bristol-myers Squibb |
PTAB Cases with Bristol-myers Squibb as patent owner: | See PTAB cases with Bristol-myers Squibb as patent owner |
Drugs and US Patents for Bristol-myers Squibb
International Patents for Bristol-myers Squibb Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 3321263 | ⤷ Try a Trial |
Mexico | 2009001426 | ⤷ Try a Trial |
Lithuania | C2049522 | ⤷ Try a Trial |
Denmark | 2784075 | ⤷ Try a Trial |
Cyprus | 2015004 | ⤷ Try a Trial |
Eurasian Patent Organization | 015756 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bristol-myers Squibb Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2049522 | PA2015006,C2049522 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: DAKLATASVIRAS IR JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS, YPAC DAKLATASVIRO HIDROCHLORIDAS; REGISTRATION NO/DATE: EU/1/14/939/001 - EU/1/14/939/004, 2 00140822 |
2049522 | 1590007-9 | Sweden | ⤷ Try a Trial | PRODUCT NAME: DACLATASVIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ESPECIALLY DACLATASVIR DIHYDROCHLORIDE; REG. NO/DATE: EU/1/14/939 20140826 |
2049522 | 2015C/006 | Belgium | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGEMENT DE NOM DU PROPRIETAIRE |
2049522 | 211 50001-2015 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: DAKLATASVIR DIHYDROCHLORID; REGISTRATION NO/DATE: EU/1/14/939 - EU/1/14/939/004 20140826 |
2049522 | SPC/GB15/003 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DACLATASVIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ESPECIALLY DACLATASVIR DIHYDROCHLORIDE; REGISTERED: UK EU/1/14/939/001-004 20140826 |
2049522 | 2015/002 | Ireland | ⤷ Try a Trial | PRODUCT NAME: DACLATASVIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ESPECIALLY DACLATASVIR DIHYDROCHLORIDE; REGISTRATION NO/DATE: EU/14/939/001-004 20140826 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.